Anti-tumor agent comprising tegafurgimeracil-oteracil potassium combination drug and oxaliplatin

Details for Australian Patent Application No. 2010248710 (hide)

Owner TAIHO PHARMACEUTICAL CO., LTD.

Inventors Fukushima, Masakazu

Agent Griffith Hack

Pub. Number AU-A-2010248710

PCT Pub. Number WO2010/131460

Priority 2009-115847 12.05.09 JP

Filing date 11 May 2010

Wipo publication date 18 November 2010

International Classifications

A61K 31/282 (2006.01)

A61K 31/404 (2006.01)

A61K 31/4412 (2006.01) - having oxo groups directly attached to the heterocyclic ring

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

1 December 2011 PCT application entered the National Phase

  PCT publication WO2010/131460 Priority application(s): WO2010/131460

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010248758-Methods of treating HIV patients with anti-fibrotics

2010248702-TTK peptides and vaccines including the same